(OXY) Occidental Petroleum - Overview
Sector: EnergyIndustry: Oil & Gas E&P | Exchange NYSE (USA) | Currency USD | Market Cap: 64.778m | Total Return 35.2% in 12m
Stock: Oil, Natural Gas, NGLs, Condensate, Midstream
Total Rating 46
Risk 62
Buy Signal 0.42
| Risk 5d forecast | |
|---|---|
| Volatility | 34.6% |
| Relative Tail Risk | -3.13% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.86 |
| Alpha | 23.81 |
| Character TTM | |
|---|---|
| Beta | 0.711 |
| Beta Downside | 1.158 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.94% |
| CAGR/Max DD | 0.07 |
EPS (Earnings per Share)
Revenue
Description: OXY Occidental Petroleum February 28, 2026
Occidental Petroleum (OXY) is an integrated oil and gas company headquartered in Houston, Texas, that acquires, explores, develops, and produces crude oil, condensate, natural-gas liquids (NGLs) and natural gas in the United States and abroad, while its Midstream and Marketing segment handles gathering, processing, transportation, storage, and marketing of these hydrocarbons as well as carbon dioxide and power.
In its latest quarterly report (Q4 2023), OXY delivered adjusted earnings of $0.73 per share on a production base of roughly 1.2 million barrels of oil equivalent per day, generating $2.5 billion of operating cash flow and reducing net debt to about $13 billion-a modest improvement amid a 12 % YoY rise in average realized oil prices driven by OPEC+ supply curbs and robust U.S. demand. The company’s midstream assets now handle over 1 billion cubic feet of natural gas per day, positioning OXY to capture value from the growing U.S. gas-to-power market and emerging carbon-capture projects.
For a deeper quantitative dive, you might explore the ValueRay platform.
Headlines to watch out for
- Global crude oil prices dictate exploration and production revenue
- Domestic natural gas prices impact profitability and investment
- Regulatory changes on carbon emissions affect operational costs
- Midstream infrastructure utilization drives marketing segment earnings
- Geopolitical stability influences international oil and gas operations
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 2.29b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.53 > 1.0 |
| NWC/Revenue: -2.42% < 20% (prev -1.66%; Δ -0.75% < -1%) |
| CFO/TA 0.12 > 3% & CFO 10.53b > Net Income 2.29b |
| Net Debt (21.97b) to EBITDA (12.45b): 1.76 < 3 |
| Current Ratio: 0.94 > 1.5 & < 3 |
| Outstanding Shares: last quarter (988.0m) vs 12m ago 5.02% < -2% |
| Gross Margin: 32.05% > 18% (prev 0.36%; Δ 3.17k% > 0.5%) |
| Asset Turnover: 28.87% > 50% (prev 31.72%; Δ -2.84% > 0%) |
| Interest Coverage Ratio: 5.07 > 6 (EBITDA TTM 12.45b / Interest Expense TTM 900.0m) |
Altman Z'' 1.60
| A: -0.01 (Total Current Assets 8.83b - Total Current Liabilities 9.43b) / Total Assets 86.78b |
| B: 0.25 (Retained Earnings 21.89b / Total Assets 86.78b) |
| C: 0.05 (EBIT TTM 4.57b / Avg Total Assets 86.11b) |
| D: 0.45 (Book Value of Equity 22.34b / Total Liabilities 50.19b) |
| Altman-Z'' Score: 1.60 = BB |
Beneish M -2.51
| DSRI: 0.85 (Receivables 3.31b/4.25b, Revenue 24.86b/27.10b) |
| GMI: 1.11 (GM 32.05% / 35.61%) |
| AQI: 2.18 (AQ_t 0.15 / AQ_t-1 0.07) |
| SGI: 0.92 (Revenue 24.86b / 27.10b) |
| TATA: -0.09 (NI 2.29b - CFO 10.53b) / TA 86.78b) |
| Beneish M-Score: -2.51 (Cap -4..+1) = A |
What is the price of OXY shares?
As of March 30, 2026, the stock is trading at USD 65.32 with a total of 20,171,065 shares traded.
Over the past week, the price has changed by +8.31%, over one month by +23.64%, over three months by +62.41% and over the past year by +35.20%.
Over the past week, the price has changed by +8.31%, over one month by +23.64%, over three months by +62.41% and over the past year by +35.20%.
Is OXY a buy, sell or hold?
Occidental Petroleum has received a consensus analysts rating of 3.33.
Therefor, it is recommend to hold OXY.
- StrongBuy: 4
- Buy: 4
- Hold: 17
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the OXY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 58.4 | -10.6% |
| Analysts Target Price | 58.4 | -10.6% |
OXY Fundamental Data Overview March 28, 2026
P/E Trailing = 48.3852
P/E Forward = 44.0529
P/S = 2.9999
P/B = 2.1579
P/EG = 3.4613
Revenue TTM = 24.86b USD
EBIT TTM = 4.57b USD
EBITDA TTM = 12.45b USD
Long Term Debt = 19.82b USD (from longTermDebt, last quarter)
Short Term Debt = 2.12b USD (from shortTermDebt, last quarter)
Debt = 23.96b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 21.97b USD (from netDebt column, last quarter)
Enterprise Value = 86.77b USD (64.78b + Debt 23.96b - CCE 1.97b)
Interest Coverage Ratio = 5.07 (Ebit TTM 4.57b / Interest Expense TTM 900.0m)
EV/FCF = 21.14x (Enterprise Value 86.77b / FCF TTM 4.11b)
FCF Yield = 4.73% (FCF TTM 4.11b / Enterprise Value 86.77b)
FCF Margin = 16.51% (FCF TTM 4.11b / Revenue TTM 24.86b)
Net Margin = 9.23% (Net Income TTM 2.29b / Revenue TTM 24.86b)
Gross Margin = 32.05% ((Revenue TTM 24.86b - Cost of Revenue TTM 16.89b) / Revenue TTM)
Gross Margin QoQ = 27.81% (prev 32.62%)
Tobins Q-Ratio = 1.00 (Enterprise Value 86.77b / Total Assets 86.78b)
Interest Expense / Debt = 0.15% (Interest Expense 36.0m / Debt 23.96b)
Taxrate = 42.61% (173.0m / 406.0m)
NOPAT = 2.62b (EBIT 4.57b * (1 - 42.61%))
Current Ratio = 0.94 (Total Current Assets 8.83b / Total Current Liabilities 9.43b)
Debt / Equity = 0.66 (Debt 23.96b / totalStockholderEquity, last quarter 36.03b)
Debt / EBITDA = 1.76 (Net Debt 21.97b / EBITDA 12.45b)
Debt / FCF = 5.35 (Net Debt 21.97b / FCF TTM 4.11b)
Total Stockholder Equity = 35.68b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.66% (Net Income 2.29b / Total Assets 86.78b)
RoE = 6.43% (Net Income TTM 2.29b / Total Stockholder Equity 35.68b)
RoCE = 8.23% (EBIT 4.57b / Capital Employed (Equity 35.68b + L.T.Debt 19.82b))
RoIC = 5.23% (NOPAT 2.62b / Invested Capital 50.11b)
WACC = 6.21% (E(64.78b)/V(88.73b) * Re(8.48%) + D(23.96b)/V(88.73b) * Rd(0.15%) * (1-Tc(0.43)))
Discount Rate = 8.48% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.98%
[DCF] Terminal Value 82.53% ; FCFF base≈4.26b ; Y1≈3.36b ; Y5≈2.21b
[DCF] Fair Price = 41.85 (EV 63.47b - Net Debt 21.97b = Equity 41.50b / Shares 991.7m; r=6.21% [WACC]; 5y FCF grow -25.35% → 3.0% )
EPS Correlation: -84.90 | EPS CAGR: -40.11% | SUE: -0.54 | # QB: 0
Revenue Correlation: -80.08 | Revenue CAGR: -12.34% | SUE: -4.0 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.90 | Chg7d=+0.270 | Chg30d=+0.632 | Revisions Net=+6 | Analysts=19
EPS current Year (2026-12-31): EPS=3.04 | Chg7d=+0.880 | Chg30d=+1.669 | Revisions Net=+7 | Growth EPS=+37.6% | Growth Revenue=+5.4%
EPS next Year (2027-12-31): EPS=2.80 | Chg7d=+0.477 | Chg30d=+0.830 | Revisions Net=+9 | Growth EPS=-8.1% | Growth Revenue=+2.9%
[Analyst] Revisions Ratio: +1.00 (6 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.4% (Discount Rate 8.5% - Earnings Yield 2.1%)
[Growth] Growth Spread = -15.8% (Analyst -9.3% - Implied 6.4%)
P/E Forward = 44.0529
P/S = 2.9999
P/B = 2.1579
P/EG = 3.4613
Revenue TTM = 24.86b USD
EBIT TTM = 4.57b USD
EBITDA TTM = 12.45b USD
Long Term Debt = 19.82b USD (from longTermDebt, last quarter)
Short Term Debt = 2.12b USD (from shortTermDebt, last quarter)
Debt = 23.96b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 21.97b USD (from netDebt column, last quarter)
Enterprise Value = 86.77b USD (64.78b + Debt 23.96b - CCE 1.97b)
Interest Coverage Ratio = 5.07 (Ebit TTM 4.57b / Interest Expense TTM 900.0m)
EV/FCF = 21.14x (Enterprise Value 86.77b / FCF TTM 4.11b)
FCF Yield = 4.73% (FCF TTM 4.11b / Enterprise Value 86.77b)
FCF Margin = 16.51% (FCF TTM 4.11b / Revenue TTM 24.86b)
Net Margin = 9.23% (Net Income TTM 2.29b / Revenue TTM 24.86b)
Gross Margin = 32.05% ((Revenue TTM 24.86b - Cost of Revenue TTM 16.89b) / Revenue TTM)
Gross Margin QoQ = 27.81% (prev 32.62%)
Tobins Q-Ratio = 1.00 (Enterprise Value 86.77b / Total Assets 86.78b)
Interest Expense / Debt = 0.15% (Interest Expense 36.0m / Debt 23.96b)
Taxrate = 42.61% (173.0m / 406.0m)
NOPAT = 2.62b (EBIT 4.57b * (1 - 42.61%))
Current Ratio = 0.94 (Total Current Assets 8.83b / Total Current Liabilities 9.43b)
Debt / Equity = 0.66 (Debt 23.96b / totalStockholderEquity, last quarter 36.03b)
Debt / EBITDA = 1.76 (Net Debt 21.97b / EBITDA 12.45b)
Debt / FCF = 5.35 (Net Debt 21.97b / FCF TTM 4.11b)
Total Stockholder Equity = 35.68b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.66% (Net Income 2.29b / Total Assets 86.78b)
RoE = 6.43% (Net Income TTM 2.29b / Total Stockholder Equity 35.68b)
RoCE = 8.23% (EBIT 4.57b / Capital Employed (Equity 35.68b + L.T.Debt 19.82b))
RoIC = 5.23% (NOPAT 2.62b / Invested Capital 50.11b)
WACC = 6.21% (E(64.78b)/V(88.73b) * Re(8.48%) + D(23.96b)/V(88.73b) * Rd(0.15%) * (1-Tc(0.43)))
Discount Rate = 8.48% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.98%
[DCF] Terminal Value 82.53% ; FCFF base≈4.26b ; Y1≈3.36b ; Y5≈2.21b
[DCF] Fair Price = 41.85 (EV 63.47b - Net Debt 21.97b = Equity 41.50b / Shares 991.7m; r=6.21% [WACC]; 5y FCF grow -25.35% → 3.0% )
EPS Correlation: -84.90 | EPS CAGR: -40.11% | SUE: -0.54 | # QB: 0
Revenue Correlation: -80.08 | Revenue CAGR: -12.34% | SUE: -4.0 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.90 | Chg7d=+0.270 | Chg30d=+0.632 | Revisions Net=+6 | Analysts=19
EPS current Year (2026-12-31): EPS=3.04 | Chg7d=+0.880 | Chg30d=+1.669 | Revisions Net=+7 | Growth EPS=+37.6% | Growth Revenue=+5.4%
EPS next Year (2027-12-31): EPS=2.80 | Chg7d=+0.477 | Chg30d=+0.830 | Revisions Net=+9 | Growth EPS=-8.1% | Growth Revenue=+2.9%
[Analyst] Revisions Ratio: +1.00 (6 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.4% (Discount Rate 8.5% - Earnings Yield 2.1%)
[Growth] Growth Spread = -15.8% (Analyst -9.3% - Implied 6.4%)